Safety and efficacy of intrathecal hyperbaric Ropivacaine vs Bupivacaine in elective lower segment caesarean section.

Safety and efficacy of intrathecal hyperbaric Ropivacaine 0.75 percent vs Bupivacaine 0.5 percent in elective lower segment caesarean section A prospective randomised study - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090208

Enrollment

160

Registered

2025-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Hyperbaric Bupivacaine 0.5 percent: Spinal drug Hyperbaric Bupivacaine 0.5 percent in elective lower segment caesarean sections. Pulse rate and Blood pressure measured at time intervals

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 2 Gestational age between 37 to 42 weeks Giving consent

Exclusion criteria

Exclusion criteria: Patient height less than 150cms Spinal deformity Allergy to drug ASA grade3 and above Refused for consent

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of ropivacaine and bupivacaine on hemodynamic changes in pregnant patients undergoing caesarean section.Timepoint: Baseline and every 2 minutes till 30 minutes then every 10 minutes till the end of surgery	—

Secondary

Measure	Time frame
To measure the onset of sensory and motor block and duration of sensory and motor blockadeTimepoint: Baseline and every 2 minutes till 30 minutes then every 10 minutes till the end of surgery	—

Countries

India

Contacts

Public ContactDr Pulla Sharath Chandra

D Y Patil Hospital

surekha.patil@gmail.com9930923108

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026